Bharat Immunolog

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE994B01014
NSEID:
BSEID: 524663

INR

18.69

-0.14 (-0.74%)

BSENSE

Dec 19

BSE+NSE Vol: 41.71 k

{
  "main_header": {
    "sid": 936506,
    "name": "Bharat Immunolog",
    "stock_name": "Bharat Immunolog",
    "full_name": "Bharat Immunological & Biological Corporation Ltd",
    "name_url": "stocks-analysis/bharat-immunolog",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "18.69",
    "chg": -0.14,
    "chgp": "-0.74%",
    "dir": -1,
    "prev_price": "18.83",
    "mcapval": "82.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524663,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE994B01014",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "41.71 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bharat-immunolog-936506-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Bharat Immunolog falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bharat-immunolog-fallingrising-3755680",
        "imagepath": "",
        "date": "2025-12-11 00:41:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Bharat Immunological’s stock price surged by ₹1.88 on 10 Dec, reflecting a strong intraday performance that saw the share touch a high of ₹21.34, representing a 16.36% increase from previous levels. This rise is particularly striking given the stock’s recent history of underwhelming returns. Over the past year, the stock has declined by 22.08%, contrasting sharply with the Sensex’s 3.53% gain during the same period. The year-to-date performance also highlights a 15.01% drop for the stock, while the Sensex has advanced by 8.00%. These figures underscore the stock’s long-term challenges but also highlight the significance of the recent rebound.</p>\n<p><strong>Trading Dynamics and Volatility</strong></p>\n<p>The stock’s trading activity on..."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Stock Hits 52-Week Low at Rs.18.58",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-immunological-biological-corporation-stock-hits-52-week-low-amidst-continued-downtrend-3751570",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BharatImmunolog_priceRelatedfactors_3751570.png",
        "date": "2025-12-08 13:17:33",
        "description": "Shares of Bharat Immunological & Biological Corporation touched a fresh 52-week low of Rs.18.58 today, marking a significant decline amid a broader market environment where the Sensex showed modest weakness. The stock has recorded a three-day consecutive decline, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Bharat Immunolog Sees Revision in Market Assessment Amidst Weak Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunolog-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-trends-3749851",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BharatImmunolog_mojoScore_3749851.png",
        "date": "2025-12-06 10:10:23",
        "description": "Bharat Immunolog, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The recent assessment highlights concerns across multiple analytical parameters, signalling caution for investors amid persistent underperformance and deteriorating fundamentals."
      },
      {
        "title": "Why is Bharat Immunolog falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bharat-immunolog-fallingrising-3662777",
        "imagepath": "",
        "date": "2025-10-31 22:41:08",
        "description": "As of 31-Oct, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 20.28, which reflects a decrease of 0.31 or 1.51%. The stock has underperformed its sector by 1.06% today and has been on a downward trend for the last two days, resulting in a total drop of 3.57% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has decreased by 2.31%, and it has seen a significant decline of 14.75% year-to-date, compared to a positive return of 7.42% for the benchmark Sensex. Notably, there has been a rise in investor participation, with delivery volume increasing by 141.98% against the 5-day average, suggesting some interest despite the overall negative performance.\n\nIn the broader market context, the stock's recent performance contras..."
      },
      {
        "title": "Why is Bharat Immunolog falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bharat-immunolog-fallingrising-3567147",
        "imagepath": "",
        "date": "2025-09-24 22:23:05",
        "description": "As of 24-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 21.54, down by 0.05 or 0.23%. The stock has been losing value for the last three days, with a total decline of 1.96% during this period. It is trading below all its moving averages, indicating a bearish trend. The company has not declared results in the last six months, which raises concerns about its long-term fundamental strength. Additionally, the net sales have decreased significantly by 87.03% in the latest reporting period, and the operating cash flow is at its lowest. The high debt-to-equity ratio and consistent underperformance against benchmarks further contribute to the stock's weak outlook.\n\nIn the broader market context, Bharat Immunological's performance over the past week shows a decline of 2.09%, while the Sensex has only fallen by 1.18%. This indicates that the stock is ..."
      },
      {
        "title": "Why is Bharat Immunolog falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bharat-immunolog-fallingrising-3561105",
        "imagepath": "",
        "date": "2025-09-23 22:34:11",
        "description": "As of 23-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 21.59, which reflects a decrease of 0.18 or 0.83%. The stock has been underperforming, having fallen consecutively for the last two days with a total return of -1.55% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased significantly, falling by 47.81% compared to the 5-day average, suggesting a decline in investor participation. There are no positive or negative factors available to provide further context on the stock's recent movement.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has shown a slight decline of 0.34% over the past week, Bharat Immunological has underperformed with a drop of 2.44%. Over the past month, while the Se..."
      },
      {
        "title": "Why is Bharat Immunolog falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bharat-immunolog-fallingrising-3554234",
        "imagepath": "",
        "date": "2025-09-22 22:23:17",
        "description": "As of 22-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 21.77, reflecting a change of -0.16, or -0.73%. The stock has underperformed in the short term, with a 1-week return of -0.91% and a 1-month return of -3.80%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. However, there has been a notable increase in investor participation, with delivery volume rising by 246.56% against the 5-day average, suggesting some interest despite the overall negative performance. Unfortunately, there is no information available regarding positive or negative factors that could further clarify the stock's recent movement.\n\nIn the broader market context, the stock's performance contrasts sharply with the benchmark Sensex, which has gained 0.46% over the past week and 1.05% over the pa..."
      }
    ],
    "total": 78,
    "sid": "936506",
    "stock_news_url": "https://www.marketsmojo.com/news/bharat-immunological-biological-corporation-936506"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.",
      "datetime": "07-Aug-2024",
      "details": "BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBIS LODR.",
      "datetime": "29-Feb-2024",
      "details": "BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 08th March 2024 for General Purpose.",
      "source": "BSE"
    },
    {
      "caption": "Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023.",
      "datetime": "13-Dec-2023",
      "details": "Submission of Draft Annual Report 2022-23 for AGM on 29.12.2023",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Bharat Immunolog falling/rising?

2025-12-11 00:41:19

Recent Price Movement and Market Context

Bharat Immunological’s stock price surged by ₹1.88 on 10 Dec, reflecting a strong intraday performance that saw the share touch a high of ₹21.34, representing a 16.36% increase from previous levels. This rise is particularly striking given the stock’s recent history of underwhelming returns. Over the past year, the stock has declined by 22.08%, contrasting sharply with the Sensex’s 3.53% gain during the same period. The year-to-date performance also highlights a 15.01% drop for the stock, while the Sensex has advanced by 8.00%. These figures underscore the stock’s long-term challenges but also highlight the significance of the recent rebound.

Trading Dynamics and Volatility

The stock’s trading activity on...

Bharat Immunological & Biological Corporation Stock Hits 52-Week Low at Rs.18.58

2025-12-08 13:17:33

Shares of Bharat Immunological & Biological Corporation touched a fresh 52-week low of Rs.18.58 today, marking a significant decline amid a broader market environment where the Sensex showed modest weakness. The stock has recorded a three-day consecutive decline, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Bharat Immunolog Sees Revision in Market Assessment Amidst Weak Financials

2025-12-06 10:10:23

Bharat Immunolog, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The recent assessment highlights concerns across multiple analytical parameters, signalling caution for investors amid persistent underperformance and deteriorating fundamentals.

Why is Bharat Immunolog falling/rising?

2025-10-31 22:41:08

As of 31-Oct, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 20.28, which reflects a decrease of 0.31 or 1.51%. The stock has underperformed its sector by 1.06% today and has been on a downward trend for the last two days, resulting in a total drop of 3.57% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has decreased by 2.31%, and it has seen a significant decline of 14.75% year-to-date, compared to a positive return of 7.42% for the benchmark Sensex. Notably, there has been a rise in investor participation, with delivery volume increasing by 141.98% against the 5-day average, suggesting some interest despite the overall negative performance. In the broader market context, the stock's recent performance contras...

Why is Bharat Immunolog falling/rising?

2025-09-24 22:23:05

As of 24-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 21.54, down by 0.05 or 0.23%. The stock has been losing value for the last three days, with a total decline of 1.96% during this period. It is trading below all its moving averages, indicating a bearish trend. The company has not declared results in the last six months, which raises concerns about its long-term fundamental strength. Additionally, the net sales have decreased significantly by 87.03% in the latest reporting period, and the operating cash flow is at its lowest. The high debt-to-equity ratio and consistent underperformance against benchmarks further contribute to the stock's weak outlook. In the broader market context, Bharat Immunological's performance over the past week shows a decline of 2.09%, while the Sensex has only fallen by 1.18%. This indicates that the stock is ...

Why is Bharat Immunolog falling/rising?

2025-09-23 22:34:11

As of 23-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 21.59, which reflects a decrease of 0.18 or 0.83%. The stock has been underperforming, having fallen consecutively for the last two days with a total return of -1.55% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased significantly, falling by 47.81% compared to the 5-day average, suggesting a decline in investor participation. There are no positive or negative factors available to provide further context on the stock's recent movement. Broader Market Context: In comparison to the benchmark Sensex, which has shown a slight decline of 0.34% over the past week, Bharat Immunological has underperformed with a drop of 2.44%. Over the past month, while the Se...

Why is Bharat Immunolog falling/rising?

2025-09-22 22:23:17

As of 22-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 21.77, reflecting a change of -0.16, or -0.73%. The stock has underperformed in the short term, with a 1-week return of -0.91% and a 1-month return of -3.80%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. However, there has been a notable increase in investor participation, with delivery volume rising by 246.56% against the 5-day average, suggesting some interest despite the overall negative performance. Unfortunately, there is no information available regarding positive or negative factors that could further clarify the stock's recent movement. In the broader market context, the stock's performance contrasts sharply with the benchmark Sensex, which has gained 0.46% over the past week and 1.05% over the pa...

View All News

Announcement

Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.

07-Aug-2024 | Source : BSE

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.

Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBIS LODR.

29-Feb-2024 | Source : BSE

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 08th March 2024 for General Purpose.